Buy Glenmark Pharmaceuticals, target Rs 550: Jay Thakkar
Buy Glenmark Pharmaceuticals Ltd. at a price target of Rs 550.0 and a stoploss at Rs 525 from entry point.
Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6042.06 Crore to Sales Value (93.93 % of Total Sales), Other Operating Revenue which contributed Rs 335.83 Crore to Sales Value (5.22 % of Total Sales) and Sale of services which contributed Rs 54.00 Crore to Sales Value (0.83 % of Total Sales)for the year ending 31-Mar-2018.
For the quarter ended 31-03-2019, the company has reported a Consolidated sales of Rs 2526.08 Crore, up .65 % from last quarter Sales of Rs 2509.78 Crore and up 12.38 % from last year same quarter Sales of Rs 2247.89 Crore Company has reported net profit after tax of Rs 161.66 Crore in latest quarter. The company’s top management includes Dr.Brian W Tempest, Mr.Bernard Munos, Mr.D R Mehta, Mr.Glenn Saldanha, Mr.Julio Ribeiro, Mr.Milind Sarwate, Mr.Rajesh V Desai, Mr.Sridhar Gorthi, Mr.V S Mani, Mrs.B E Saldanha, Mrs.Cherylann Pinto. Company has Walker, Chandiok & Co.LLP as its auditoRs As on 31-03-2019, the company has a total of 282,168,156 shares outstanding.